These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36238249)

  • 21. Azithromycin. A pharmacoeconomic review of its use as a single-dose regimen in the treatment of uncomplicated urogenital Chlamydia trachomatis infections in women.
    Lea AP; Lamb HM
    Pharmacoeconomics; 1997 Nov; 12(5):596-611. PubMed ID: 10174326
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Faris R; Andersen SE; McCullough A; Gourronc F; Klingelhutz AJ; Weber MM
    Front Cell Infect Microbiol; 2019; 9():399. PubMed ID: 32039039
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate.
    Ljubin-Sternak S; Mestrovic T; Vilibic-Cavlek T; Mlinaric-Galinovic G; Sviben M; Markotic A; Skerk V
    Folia Microbiol (Praha); 2013 Sep; 58(5):361-5. PubMed ID: 23271498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized, double-blind, multicenter safety and efficacy study of rifalazil compared with azithromycin for treatment of uncomplicated genital Chlamydia trachomatis infection in women.
    Geisler WM; Pascual ML; Mathew J; Koltun WD; Morgan F; Batteiger BE; Mayes A; Tao S; Hurwitz SJ; Sayada C; Schinazi RF
    Antimicrob Agents Chemother; 2014 Jul; 58(7):4014-9. PubMed ID: 24798277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of bovine lactoferrin on Chlamydia trachomatis infection and inflammation.
    Sessa R; Di Pietro M; Filardo S; Bressan A; Rosa L; Cutone A; Frioni A; Berlutti F; Paesano R; Valenti P
    Biochem Cell Biol; 2017 Feb; 95(1):34-40. PubMed ID: 28094551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single dose (direct observed) azithromycin therapy for Neisseria gonorrhoeae and Chlamydia trachomatis in STD clinic attenders with genital discharge in Trinidad and Tobago.
    Swanston WH; Prabhakar P; Barrow L; Mahabir BS; Furlonge C
    West Indian Med J; 2001 Sep; 50(3):198-202. PubMed ID: 11769023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bactericidal activity of first-choice antibiotics against gamma interferon-induced persistent infection of human epithelial cells by Chlamydia trachomatis.
    Reveneau N; Crane DD; Fischer E; Caldwell HD
    Antimicrob Agents Chemother; 2005 May; 49(5):1787-93. PubMed ID: 15855497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the Extracellular Signal-Regulated Kinase/Ribosomal S6 Kinase Cascade Limits Chlamydia trachomatis Infection.
    Xue Y; Chen W; Mai Z; Yu X; Wu Q; Wan C; Su X; Wu Y; Rong Z; Zheng H
    J Invest Dermatol; 2021 Apr; 141(4):852-862.e6. PubMed ID: 32918951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of fluoroquinolones, azithromycin and doxycycline against chlamydia trachomatis cultured from men with chronic lower urinary tract symptoms.
    Smelov V; Perekalina T; Gorelov A; Smelova N; Artemenko N; Norman L
    Eur Urol; 2004 Nov; 46(5):647-50. PubMed ID: 15474277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of doxycycline with azithromycin in treatment of pharyngeal chlamydia infection.
    Manavi K; Hettiarachchi N; Hodson J
    Int J STD AIDS; 2016 Dec; 27(14):1303-1308. PubMed ID: 26511655
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new therapeutic approach in the treatment of genital chlamydial infections. Azithromycin (Sumamed)].
    Borisov I
    Akush Ginekol (Sofiia); 1998; 37(3):58-62. PubMed ID: 10204275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficacy and safety of azithromycin in the treatment of female genital Chlamydia trachomatis infections].
    Narcio Reyes LE; Casanova Roman G; Arredondo Garcia JL
    Ginecol Obstet Mex; 1993 Sep; 61():261-4. PubMed ID: 8406112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage.
    Vicetti Miguel RD; Quispe Calla NE; Pavelko SD; Cherpes TL
    PLoS One; 2016; 11(9):e0162445. PubMed ID: 27606424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiazolino 2-Pyridone Amide Inhibitors of Chlamydia trachomatis Infectivity.
    Good JA; Silver J; Núñez-Otero C; Bahnan W; Krishnan KS; Salin O; Engström P; Svensson R; Artursson P; Gylfe Å; Bergström S; Almqvist F
    J Med Chem; 2016 Mar; 59(5):2094-108. PubMed ID: 26849778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Azithromycin treatment modulates cytokine production in Chlamydia trachomatis infected women.
    Srivastava P; Jha HC; Salhan S; Mittal A
    Basic Clin Pharmacol Toxicol; 2009 Jun; 104(6):478-82. PubMed ID: 19389045
    [No Abstract]   [Full Text] [Related]  

  • 36. Time to clearance of Chlamydia trachomatis ribosomal RNA in women treated for chlamydial infection.
    Renault CA; Israelski DM; Levy V; Fujikawa BK; Kellogg TA; Klausner JD
    Sex Health; 2011 Mar; 8(1):69-73. PubMed ID: 21371385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of Chlamydia trachomatis clearance in patients with azithromycin, as assessed by first void urine testing by PCR and transcription-mediated amplification.
    Bianchi A; Bogard M; Cessot G; Bohbot JM; Malkin JE; Alonso JM
    Sex Transm Dis; 1998 Aug; 25(7):366-7. PubMed ID: 9713917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of five different antibiotic regimens for the treatment of uncomplicated Chlamydia trachomatis cervicitis.
    Nuovo J; Melnikow J; Paliescheskey M; King J; Mowers R
    J Am Board Fam Pract; 1995; 8(1):7-16. PubMed ID: 7701965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Examination of Chlamydia trachomatis infection in environments mimicking normal and abnormal vaginal pH.
    Yasin B; Pang M; Wagar EA; Lehrer RI
    Sex Transm Dis; 2002 Sep; 29(9):514-9. PubMed ID: 12218842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic antimicrobial susceptibility testing of Chlamydia trachomatis isolates from patients with persistent or successfully treated infections.
    Pitt R; Alexander S; Ison C; Horner P; Hathorn E; Goold P; Woodford N; Cole MJ
    J Antimicrob Chemother; 2018 Mar; 73(3):680-686. PubMed ID: 29207004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.